nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Irinotecan—stomach cancer	0.168	0.272	CbGbCtD
Eprosartan—ABCC2—Docetaxel—stomach cancer	0.123	0.199	CbGbCtD
Eprosartan—ABCC2—Doxorubicin—stomach cancer	0.0916	0.149	CbGbCtD
Eprosartan—CYP2C9—Capecitabine—stomach cancer	0.0912	0.148	CbGbCtD
Eprosartan—ABCC2—Methotrexate—stomach cancer	0.0888	0.144	CbGbCtD
Eprosartan—CYP2C9—Fluorouracil—stomach cancer	0.0541	0.0877	CbGbCtD
Eprosartan—ABCC2—bile—stomach cancer	0.018	0.32	CbGeAlD
Eprosartan—AGTR1—blood vessel—stomach cancer	0.00733	0.13	CbGeAlD
Eprosartan—AGTR1—hematopoietic system—stomach cancer	0.0039	0.0695	CbGeAlD
Eprosartan—AGTR1—epithelium—stomach cancer	0.00357	0.0635	CbGeAlD
Eprosartan—AGTR1—smooth muscle tissue—stomach cancer	0.00344	0.0612	CbGeAlD
Eprosartan—AGTR1—lymphoid tissue—stomach cancer	0.00275	0.0489	CbGeAlD
Eprosartan—AGTR1—endocrine gland—stomach cancer	0.00224	0.0399	CbGeAlD
Eprosartan—AGTR1—liver—stomach cancer	0.00202	0.036	CbGeAlD
Eprosartan—ABCC2—digestive system—stomach cancer	0.00196	0.0349	CbGeAlD
Eprosartan—CYP2C9—hematopoietic system—stomach cancer	0.00188	0.0335	CbGeAlD
Eprosartan—Losartan—ACE—stomach cancer	0.00164	0.709	CrCbGaD
Eprosartan—ABCC2—endocrine gland—stomach cancer	0.00162	0.0289	CbGeAlD
Eprosartan—AGTR1—lymph node—stomach cancer	0.00155	0.0276	CbGeAlD
Eprosartan—ABCC2—liver—stomach cancer	0.00146	0.026	CbGeAlD
Eprosartan—CYP2C9—digestive system—stomach cancer	0.00131	0.0233	CbGeAlD
Eprosartan—ABCC2—lymph node—stomach cancer	0.00112	0.02	CbGeAlD
Eprosartan—CYP2C9—endocrine gland—stomach cancer	0.00108	0.0192	CbGeAlD
Eprosartan—CYP2C9—liver—stomach cancer	0.000973	0.0173	CbGeAlD
Eprosartan—Losartan—ALB—stomach cancer	0.000671	0.291	CrCbGaD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	0.000468	0.00791	CbGpPWpGaD
Eprosartan—ABCC2—ABC-family proteins mediated transport—APOA1—stomach cancer	0.000447	0.00755	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MMP2—stomach cancer	0.000445	0.00753	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—KISS1R—stomach cancer	0.000439	0.00742	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RGS2—stomach cancer	0.000432	0.00729	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—stomach cancer	0.000432	0.00729	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NOS3—stomach cancer	0.000417	0.00705	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HRH4—stomach cancer	0.000417	0.00705	CbGpPWpGaD
Eprosartan—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000412	0.00697	CbGpPWpGaD
Eprosartan—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.000412	0.00696	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—KISS1—stomach cancer	0.000372	0.00628	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—F2R—stomach cancer	0.000362	0.00611	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—AGTR2—stomach cancer	0.000361	0.0061	CbGpPWpGaD
Eprosartan—AGTR1—Arf6 signaling events—EGFR—stomach cancer	0.00036	0.00608	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—F2R—stomach cancer	0.000357	0.00603	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—ANXA1—stomach cancer	0.00034	0.00575	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—ANXA1—stomach cancer	0.000336	0.00567	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—ALOX5—stomach cancer	0.000335	0.00566	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—CDKN1A—stomach cancer	0.000334	0.00564	CbGpPWpGaD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK8—stomach cancer	0.000326	0.0055	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CASP8—stomach cancer	0.000325	0.00549	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—F2R—stomach cancer	0.000323	0.00547	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—HRH4—stomach cancer	0.000318	0.00537	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000314	0.00531	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—TGFA—stomach cancer	0.000309	0.00522	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—SERPINA1—stomach cancer	0.000304	0.00514	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—stomach cancer	0.000304	0.00514	CbGpPWpGaD
Eprosartan—Conjunctivitis—Epirubicin—stomach cancer	0.000289	0.00108	CcSEcCtD
Eprosartan—Urinary tract infection—Epirubicin—stomach cancer	0.000289	0.00108	CcSEcCtD
Eprosartan—Hypersensitivity—Fluorouracil—stomach cancer	0.000287	0.00108	CcSEcCtD
Eprosartan—Dry mouth—Docetaxel—stomach cancer	0.000286	0.00108	CcSEcCtD
Eprosartan—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000286	0.00108	CcSEcCtD
Eprosartan—Pollakiuria—Doxorubicin—stomach cancer	0.000285	0.00107	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK3—stomach cancer	0.000284	0.00481	CbGpPWpGaD
Eprosartan—Chest pain—Capecitabine—stomach cancer	0.000284	0.00107	CcSEcCtD
Eprosartan—Arthralgia—Capecitabine—stomach cancer	0.000284	0.00107	CcSEcCtD
Eprosartan—Myalgia—Capecitabine—stomach cancer	0.000284	0.00107	CcSEcCtD
Eprosartan—Haematuria—Epirubicin—stomach cancer	0.000283	0.00106	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—KISS1—stomach cancer	0.000283	0.00478	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—AGTR2—stomach cancer	0.000283	0.00478	CbGpPWpGaD
Eprosartan—Pharyngitis—Methotrexate—stomach cancer	0.000283	0.00106	CcSEcCtD
Eprosartan—Anxiety—Capecitabine—stomach cancer	0.000283	0.00106	CcSEcCtD
Eprosartan—CYP2C9—Arachidonic acid metabolism—AKR1C3—stomach cancer	0.00028	0.00474	CbGpPWpGaD
Eprosartan—Discomfort—Capecitabine—stomach cancer	0.00028	0.00105	CcSEcCtD
Eprosartan—Epistaxis—Epirubicin—stomach cancer	0.00028	0.00105	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—F2R—stomach cancer	0.00028	0.00472	CbGpPWpGaD
Eprosartan—Sinusitis—Epirubicin—stomach cancer	0.000279	0.00105	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—CYP2A6—stomach cancer	0.000278	0.0047	CbGpPWpGaD
Eprosartan—Hyperglycaemia—Doxorubicin—stomach cancer	0.000278	0.00104	CcSEcCtD
Eprosartan—Diarrhoea—Irinotecan—stomach cancer	0.000278	0.00104	CcSEcCtD
Eprosartan—Dry mouth—Capecitabine—stomach cancer	0.000277	0.00104	CcSEcCtD
Eprosartan—Shock—Docetaxel—stomach cancer	0.000276	0.00104	CcSEcCtD
Eprosartan—Pruritus—Fluorouracil—stomach cancer	0.000275	0.00103	CcSEcCtD
Eprosartan—Thrombocytopenia—Docetaxel—stomach cancer	0.000275	0.00103	CcSEcCtD
Eprosartan—Visual impairment—Methotrexate—stomach cancer	0.000274	0.00103	CcSEcCtD
Eprosartan—Tachycardia—Docetaxel—stomach cancer	0.000274	0.00103	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR1A—stomach cancer	0.000272	0.0046	CbGpPWpGaD
Eprosartan—Bradycardia—Epirubicin—stomach cancer	0.000271	0.00102	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—MAPK1—stomach cancer	0.000271	0.00457	CbGpPWpGaD
Eprosartan—Renal failure—Doxorubicin—stomach cancer	0.00027	0.00101	CcSEcCtD
Eprosartan—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000269	0.00101	CcSEcCtD
Eprosartan—Dizziness—Irinotecan—stomach cancer	0.000269	0.00101	CcSEcCtD
Eprosartan—Anorexia—Docetaxel—stomach cancer	0.000268	0.00101	CcSEcCtD
Eprosartan—Shock—Capecitabine—stomach cancer	0.000267	0.001	CcSEcCtD
Eprosartan—Rhinitis—Epirubicin—stomach cancer	0.000267	0.001	CcSEcCtD
Eprosartan—Conjunctivitis—Doxorubicin—stomach cancer	0.000267	0.001	CcSEcCtD
Eprosartan—Urinary tract infection—Doxorubicin—stomach cancer	0.000267	0.001	CcSEcCtD
Eprosartan—Diarrhoea—Fluorouracil—stomach cancer	0.000266	0.001	CcSEcCtD
Eprosartan—Thrombocytopenia—Capecitabine—stomach cancer	0.000266	0.001	CcSEcCtD
Eprosartan—Tinnitus—Methotrexate—stomach cancer	0.000266	0.000998	CcSEcCtD
Eprosartan—Tachycardia—Capecitabine—stomach cancer	0.000265	0.000997	CcSEcCtD
Eprosartan—Pharyngitis—Epirubicin—stomach cancer	0.000265	0.000994	CcSEcCtD
Eprosartan—Hyperhidrosis—Capecitabine—stomach cancer	0.000263	0.000987	CcSEcCtD
Eprosartan—Oedema peripheral—Epirubicin—stomach cancer	0.000263	0.000987	CcSEcCtD
Eprosartan—Hypotension—Docetaxel—stomach cancer	0.000262	0.000986	CcSEcCtD
Eprosartan—Haematuria—Doxorubicin—stomach cancer	0.000262	0.000984	CcSEcCtD
Eprosartan—Epistaxis—Doxorubicin—stomach cancer	0.000259	0.000974	CcSEcCtD
Eprosartan—Anorexia—Capecitabine—stomach cancer	0.000259	0.000974	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HBEGF—stomach cancer	0.000259	0.00437	CbGpPWpGaD
Eprosartan—Vomiting—Irinotecan—stomach cancer	0.000258	0.00097	CcSEcCtD
Eprosartan—Sinusitis—Doxorubicin—stomach cancer	0.000258	0.000968	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—stomach cancer	0.000258	0.00435	CbGpPWpGaD
Eprosartan—Dizziness—Fluorouracil—stomach cancer	0.000257	0.000966	CcSEcCtD
Eprosartan—Visual impairment—Epirubicin—stomach cancer	0.000257	0.000965	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—CXCL8—stomach cancer	0.000257	0.00434	CbGpPWpGaD
Eprosartan—Rash—Irinotecan—stomach cancer	0.000256	0.000962	CcSEcCtD
Eprosartan—Dermatitis—Irinotecan—stomach cancer	0.000256	0.000961	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000256	0.000961	CcSEcCtD
Eprosartan—Chills—Methotrexate—stomach cancer	0.000256	0.00096	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB1—stomach cancer	0.000255	0.0043	CbGpPWpGaD
Eprosartan—Headache—Irinotecan—stomach cancer	0.000254	0.000956	CcSEcCtD
Eprosartan—Hypotension—Capecitabine—stomach cancer	0.000254	0.000954	CcSEcCtD
Eprosartan—Insomnia—Docetaxel—stomach cancer	0.000254	0.000954	CcSEcCtD
Eprosartan—Paraesthesia—Docetaxel—stomach cancer	0.000252	0.000947	CcSEcCtD
Eprosartan—Bradycardia—Doxorubicin—stomach cancer	0.000251	0.000943	CcSEcCtD
Eprosartan—Dyspnoea—Docetaxel—stomach cancer	0.00025	0.00094	CcSEcCtD
Eprosartan—Somnolence—Docetaxel—stomach cancer	0.00025	0.000938	CcSEcCtD
Eprosartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.000249	0.00421	CbGpPWpGaD
Eprosartan—Tinnitus—Epirubicin—stomach cancer	0.000249	0.000934	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—KISS1R—stomach cancer	0.000248	0.00419	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000248	0.00093	CcSEcCtD
Eprosartan—Vomiting—Fluorouracil—stomach cancer	0.000247	0.000929	CcSEcCtD
Eprosartan—Rhinitis—Doxorubicin—stomach cancer	0.000247	0.000929	CcSEcCtD
Eprosartan—Dyspepsia—Docetaxel—stomach cancer	0.000247	0.000929	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IL1B—stomach cancer	0.000246	0.00416	CbGpPWpGaD
Eprosartan—Insomnia—Capecitabine—stomach cancer	0.000246	0.000924	CcSEcCtD
Eprosartan—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000246	0.00415	CbGpPWpGaD
Eprosartan—Rash—Fluorouracil—stomach cancer	0.000245	0.000922	CcSEcCtD
Eprosartan—Dermatitis—Fluorouracil—stomach cancer	0.000245	0.000921	CcSEcCtD
Eprosartan—Pharyngitis—Doxorubicin—stomach cancer	0.000245	0.00092	CcSEcCtD
Eprosartan—Paraesthesia—Capecitabine—stomach cancer	0.000244	0.000917	CcSEcCtD
Eprosartan—Decreased appetite—Docetaxel—stomach cancer	0.000244	0.000917	CcSEcCtD
Eprosartan—Headache—Fluorouracil—stomach cancer	0.000244	0.000916	CcSEcCtD
Eprosartan—Oedema peripheral—Doxorubicin—stomach cancer	0.000243	0.000913	CcSEcCtD
Eprosartan—Dyspnoea—Capecitabine—stomach cancer	0.000242	0.000911	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—stomach cancer	0.000242	0.00409	CbGpPWpGaD
Eprosartan—Fatigue—Docetaxel—stomach cancer	0.000242	0.000909	CcSEcCtD
Eprosartan—Nausea—Irinotecan—stomach cancer	0.000241	0.000906	CcSEcCtD
Eprosartan—Constipation—Docetaxel—stomach cancer	0.00024	0.000902	CcSEcCtD
Eprosartan—Pain—Docetaxel—stomach cancer	0.00024	0.000902	CcSEcCtD
Eprosartan—Back pain—Methotrexate—stomach cancer	0.00024	0.000901	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—F2R—stomach cancer	0.00024	0.00405	CbGpPWpGaD
Eprosartan—Dyspepsia—Capecitabine—stomach cancer	0.000239	0.000899	CcSEcCtD
Eprosartan—Chills—Epirubicin—stomach cancer	0.000239	0.000899	CcSEcCtD
Eprosartan—Visual impairment—Doxorubicin—stomach cancer	0.000238	0.000893	CcSEcCtD
Eprosartan—Decreased appetite—Capecitabine—stomach cancer	0.000236	0.000888	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—stomach cancer	0.000235	0.00397	CbGpPWpGaD
Eprosartan—Fatigue—Capecitabine—stomach cancer	0.000234	0.000881	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR1A—stomach cancer	0.000233	0.00394	CbGpPWpGaD
Eprosartan—Pain—Capecitabine—stomach cancer	0.000232	0.000873	CcSEcCtD
Eprosartan—Constipation—Capecitabine—stomach cancer	0.000232	0.000873	CcSEcCtD
Eprosartan—Feeling abnormal—Docetaxel—stomach cancer	0.000231	0.000869	CcSEcCtD
Eprosartan—Nausea—Fluorouracil—stomach cancer	0.000231	0.000868	CcSEcCtD
Eprosartan—Ill-defined disorder—Methotrexate—stomach cancer	0.00023	0.000864	CcSEcCtD
Eprosartan—Tinnitus—Doxorubicin—stomach cancer	0.00023	0.000864	CcSEcCtD
Eprosartan—Gastrointestinal pain—Docetaxel—stomach cancer	0.00023	0.000863	CcSEcCtD
Eprosartan—Flatulence—Epirubicin—stomach cancer	0.000229	0.000859	CcSEcCtD
Eprosartan—Tension—Epirubicin—stomach cancer	0.000228	0.000855	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—KISS1R—stomach cancer	0.000225	0.00381	CbGpPWpGaD
Eprosartan—Nervousness—Epirubicin—stomach cancer	0.000225	0.000847	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ANXA1—stomach cancer	0.000225	0.00381	CbGpPWpGaD
Eprosartan—Back pain—Epirubicin—stomach cancer	0.000224	0.000843	CcSEcCtD
Eprosartan—Feeling abnormal—Capecitabine—stomach cancer	0.000224	0.000842	CcSEcCtD
Eprosartan—Malaise—Methotrexate—stomach cancer	0.000224	0.00084	CcSEcCtD
Eprosartan—Muscle spasms—Epirubicin—stomach cancer	0.000223	0.000838	CcSEcCtD
Eprosartan—Vertigo—Methotrexate—stomach cancer	0.000223	0.000837	CcSEcCtD
Eprosartan—Gastrointestinal pain—Capecitabine—stomach cancer	0.000222	0.000835	CcSEcCtD
Eprosartan—Abdominal pain—Docetaxel—stomach cancer	0.000222	0.000834	CcSEcCtD
Eprosartan—Body temperature increased—Docetaxel—stomach cancer	0.000222	0.000834	CcSEcCtD
Eprosartan—Chills—Doxorubicin—stomach cancer	0.000221	0.000831	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—HBEGF—stomach cancer	0.00022	0.00372	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—stomach cancer	0.000218	0.00369	CbGpPWpGaD
Eprosartan—Cough—Methotrexate—stomach cancer	0.000216	0.000813	CcSEcCtD
Eprosartan—Urticaria—Capecitabine—stomach cancer	0.000216	0.000811	CcSEcCtD
Eprosartan—Ill-defined disorder—Epirubicin—stomach cancer	0.000215	0.000809	CcSEcCtD
Eprosartan—Body temperature increased—Capecitabine—stomach cancer	0.000215	0.000807	CcSEcCtD
Eprosartan—Abdominal pain—Capecitabine—stomach cancer	0.000215	0.000807	CcSEcCtD
Eprosartan—Flatulence—Doxorubicin—stomach cancer	0.000212	0.000795	CcSEcCtD
Eprosartan—Arthralgia—Methotrexate—stomach cancer	0.000211	0.000793	CcSEcCtD
Eprosartan—Myalgia—Methotrexate—stomach cancer	0.000211	0.000793	CcSEcCtD
Eprosartan—Chest pain—Methotrexate—stomach cancer	0.000211	0.000793	CcSEcCtD
Eprosartan—Tension—Doxorubicin—stomach cancer	0.000211	0.000792	CcSEcCtD
Eprosartan—Malaise—Epirubicin—stomach cancer	0.000209	0.000786	CcSEcCtD
Eprosartan—Discomfort—Methotrexate—stomach cancer	0.000209	0.000784	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—VEGFA—stomach cancer	0.000209	0.00352	CbGpPWpGaD
Eprosartan—Nervousness—Doxorubicin—stomach cancer	0.000209	0.000783	CcSEcCtD
Eprosartan—Vertigo—Epirubicin—stomach cancer	0.000208	0.000783	CcSEcCtD
Eprosartan—Syncope—Epirubicin—stomach cancer	0.000208	0.000782	CcSEcCtD
Eprosartan—Back pain—Doxorubicin—stomach cancer	0.000208	0.00078	CcSEcCtD
Eprosartan—Hypersensitivity—Docetaxel—stomach cancer	0.000207	0.000777	CcSEcCtD
Eprosartan—Muscle spasms—Doxorubicin—stomach cancer	0.000206	0.000776	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—stomach cancer	0.000206	0.00349	CbGpPWpGaD
Eprosartan—Palpitations—Epirubicin—stomach cancer	0.000205	0.00077	CcSEcCtD
Eprosartan—Loss of consciousness—Epirubicin—stomach cancer	0.000204	0.000766	CcSEcCtD
Eprosartan—Cough—Epirubicin—stomach cancer	0.000202	0.000761	CcSEcCtD
Eprosartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000202	0.00341	CbGpPWpGaD
Eprosartan—Asthenia—Docetaxel—stomach cancer	0.000201	0.000757	CcSEcCtD
Eprosartan—Hypersensitivity—Capecitabine—stomach cancer	0.0002	0.000752	CcSEcCtD
Eprosartan—Ill-defined disorder—Doxorubicin—stomach cancer	0.000199	0.000748	CcSEcCtD
Eprosartan—Pruritus—Docetaxel—stomach cancer	0.000199	0.000746	CcSEcCtD
Eprosartan—Thrombocytopenia—Methotrexate—stomach cancer	0.000198	0.000744	CcSEcCtD
Eprosartan—Myalgia—Epirubicin—stomach cancer	0.000198	0.000742	CcSEcCtD
Eprosartan—Arthralgia—Epirubicin—stomach cancer	0.000198	0.000742	CcSEcCtD
Eprosartan—Chest pain—Epirubicin—stomach cancer	0.000198	0.000742	CcSEcCtD
Eprosartan—Anxiety—Epirubicin—stomach cancer	0.000197	0.00074	CcSEcCtD
Eprosartan—Hyperhidrosis—Methotrexate—stomach cancer	0.000196	0.000735	CcSEcCtD
Eprosartan—Discomfort—Epirubicin—stomach cancer	0.000195	0.000733	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—GSTP1—stomach cancer	0.000195	0.0033	CbGpPWpGaD
Eprosartan—Asthenia—Capecitabine—stomach cancer	0.000195	0.000733	CcSEcCtD
Eprosartan—Malaise—Doxorubicin—stomach cancer	0.000194	0.000727	CcSEcCtD
Eprosartan—Dry mouth—Epirubicin—stomach cancer	0.000193	0.000726	CcSEcCtD
Eprosartan—Vertigo—Doxorubicin—stomach cancer	0.000193	0.000725	CcSEcCtD
Eprosartan—Anorexia—Methotrexate—stomach cancer	0.000193	0.000725	CcSEcCtD
Eprosartan—Syncope—Doxorubicin—stomach cancer	0.000193	0.000723	CcSEcCtD
Eprosartan—ABCC2—NRF2 pathway—HMOX1—stomach cancer	0.000192	0.00325	CbGpPWpGaD
Eprosartan—Pruritus—Capecitabine—stomach cancer	0.000192	0.000723	CcSEcCtD
Eprosartan—Diarrhoea—Docetaxel—stomach cancer	0.000192	0.000722	CcSEcCtD
Eprosartan—Palpitations—Doxorubicin—stomach cancer	0.00019	0.000713	CcSEcCtD
Eprosartan—Hypotension—Methotrexate—stomach cancer	0.000189	0.00071	CcSEcCtD
Eprosartan—Loss of consciousness—Doxorubicin—stomach cancer	0.000189	0.000709	CcSEcCtD
Eprosartan—Cough—Doxorubicin—stomach cancer	0.000187	0.000704	CcSEcCtD
Eprosartan—Shock—Epirubicin—stomach cancer	0.000186	0.0007	CcSEcCtD
Eprosartan—Diarrhoea—Capecitabine—stomach cancer	0.000186	0.000699	CcSEcCtD
Eprosartan—Dizziness—Docetaxel—stomach cancer	0.000186	0.000698	CcSEcCtD
Eprosartan—Thrombocytopenia—Epirubicin—stomach cancer	0.000185	0.000697	CcSEcCtD
Eprosartan—Tachycardia—Epirubicin—stomach cancer	0.000185	0.000694	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—AGTR2—stomach cancer	0.000184	0.00312	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000184	0.000693	CcSEcCtD
Eprosartan—Hyperhidrosis—Epirubicin—stomach cancer	0.000183	0.000688	CcSEcCtD
Eprosartan—Insomnia—Methotrexate—stomach cancer	0.000183	0.000688	CcSEcCtD
Eprosartan—Arthralgia—Doxorubicin—stomach cancer	0.000183	0.000687	CcSEcCtD
Eprosartan—Myalgia—Doxorubicin—stomach cancer	0.000183	0.000687	CcSEcCtD
Eprosartan—Chest pain—Doxorubicin—stomach cancer	0.000183	0.000687	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—F2R—stomach cancer	0.000182	0.00308	CbGpPWpGaD
Eprosartan—Anxiety—Doxorubicin—stomach cancer	0.000182	0.000684	CcSEcCtD
Eprosartan—Paraesthesia—Methotrexate—stomach cancer	0.000182	0.000683	CcSEcCtD
Eprosartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000181	0.00306	CbGpPWpGaD
Eprosartan—Discomfort—Doxorubicin—stomach cancer	0.000181	0.000679	CcSEcCtD
Eprosartan—Anorexia—Epirubicin—stomach cancer	0.000181	0.000678	CcSEcCtD
Eprosartan—Dyspnoea—Methotrexate—stomach cancer	0.00018	0.000678	CcSEcCtD
Eprosartan—Somnolence—Methotrexate—stomach cancer	0.00018	0.000676	CcSEcCtD
Eprosartan—Dizziness—Capecitabine—stomach cancer	0.00018	0.000675	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—HRH4—stomach cancer	0.000179	0.00303	CbGpPWpGaD
Eprosartan—ABCC2—NRF2 pathway—GSTM1—stomach cancer	0.000179	0.00303	CbGpPWpGaD
Eprosartan—Dry mouth—Doxorubicin—stomach cancer	0.000179	0.000672	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—TNF—stomach cancer	0.000179	0.00302	CbGpPWpGaD
Eprosartan—Vomiting—Docetaxel—stomach cancer	0.000179	0.000671	CcSEcCtD
Eprosartan—Dyspepsia—Methotrexate—stomach cancer	0.000178	0.000669	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—HTR1A—stomach cancer	0.000178	0.003	CbGpPWpGaD
Eprosartan—Rash—Docetaxel—stomach cancer	0.000177	0.000665	CcSEcCtD
Eprosartan—Hypotension—Epirubicin—stomach cancer	0.000177	0.000665	CcSEcCtD
Eprosartan—Dermatitis—Docetaxel—stomach cancer	0.000177	0.000664	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—stomach cancer	0.000177	0.00299	CbGpPWpGaD
Eprosartan—Decreased appetite—Methotrexate—stomach cancer	0.000176	0.000661	CcSEcCtD
Eprosartan—Headache—Docetaxel—stomach cancer	0.000176	0.000661	CcSEcCtD
Eprosartan—Fatigue—Methotrexate—stomach cancer	0.000174	0.000655	CcSEcCtD
Eprosartan—Pain—Methotrexate—stomach cancer	0.000173	0.00065	CcSEcCtD
Eprosartan—Vomiting—Capecitabine—stomach cancer	0.000173	0.000649	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000173	0.000648	CcSEcCtD
Eprosartan—Shock—Doxorubicin—stomach cancer	0.000172	0.000648	CcSEcCtD
Eprosartan—Thrombocytopenia—Doxorubicin—stomach cancer	0.000172	0.000645	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—ANXA1—stomach cancer	0.000171	0.0029	CbGpPWpGaD
Eprosartan—Rash—Capecitabine—stomach cancer	0.000171	0.000644	CcSEcCtD
Eprosartan—Insomnia—Epirubicin—stomach cancer	0.000171	0.000644	CcSEcCtD
Eprosartan—Dermatitis—Capecitabine—stomach cancer	0.000171	0.000643	CcSEcCtD
Eprosartan—Tachycardia—Doxorubicin—stomach cancer	0.000171	0.000643	CcSEcCtD
Eprosartan—Headache—Capecitabine—stomach cancer	0.00017	0.00064	CcSEcCtD
Eprosartan—Paraesthesia—Epirubicin—stomach cancer	0.00017	0.000639	CcSEcCtD
Eprosartan—Hyperhidrosis—Doxorubicin—stomach cancer	0.000169	0.000636	CcSEcCtD
Eprosartan—Dyspnoea—Epirubicin—stomach cancer	0.000169	0.000634	CcSEcCtD
Eprosartan—Somnolence—Epirubicin—stomach cancer	0.000168	0.000633	CcSEcCtD
Eprosartan—Anorexia—Doxorubicin—stomach cancer	0.000167	0.000628	CcSEcCtD
Eprosartan—Nausea—Docetaxel—stomach cancer	0.000167	0.000627	CcSEcCtD
Eprosartan—Feeling abnormal—Methotrexate—stomach cancer	0.000167	0.000627	CcSEcCtD
Eprosartan—Dyspepsia—Epirubicin—stomach cancer	0.000167	0.000626	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—ADRB1—stomach cancer	0.000166	0.00281	CbGpPWpGaD
Eprosartan—Gastrointestinal pain—Methotrexate—stomach cancer	0.000165	0.000622	CcSEcCtD
Eprosartan—Decreased appetite—Epirubicin—stomach cancer	0.000165	0.000619	CcSEcCtD
Eprosartan—Hypotension—Doxorubicin—stomach cancer	0.000164	0.000615	CcSEcCtD
Eprosartan—Fatigue—Epirubicin—stomach cancer	0.000163	0.000613	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—HRH4—stomach cancer	0.000163	0.00275	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—stomach cancer	0.000163	0.00275	CbGpPWpGaD
Eprosartan—Pain—Epirubicin—stomach cancer	0.000162	0.000608	CcSEcCtD
Eprosartan—Constipation—Epirubicin—stomach cancer	0.000162	0.000608	CcSEcCtD
Eprosartan—Nausea—Capecitabine—stomach cancer	0.000161	0.000607	CcSEcCtD
Eprosartan—Urticaria—Methotrexate—stomach cancer	0.000161	0.000604	CcSEcCtD
Eprosartan—Body temperature increased—Methotrexate—stomach cancer	0.00016	0.000601	CcSEcCtD
Eprosartan—Abdominal pain—Methotrexate—stomach cancer	0.00016	0.000601	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—KISS1—stomach cancer	0.00016	0.0027	CbGpPWpGaD
Eprosartan—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00016	0.0006	CcSEcCtD
Eprosartan—Insomnia—Doxorubicin—stomach cancer	0.000158	0.000595	CcSEcCtD
Eprosartan—Paraesthesia—Doxorubicin—stomach cancer	0.000157	0.000591	CcSEcCtD
Eprosartan—Dyspnoea—Doxorubicin—stomach cancer	0.000156	0.000587	CcSEcCtD
Eprosartan—Feeling abnormal—Epirubicin—stomach cancer	0.000156	0.000586	CcSEcCtD
Eprosartan—Somnolence—Doxorubicin—stomach cancer	0.000156	0.000585	CcSEcCtD
Eprosartan—Gastrointestinal pain—Epirubicin—stomach cancer	0.000155	0.000582	CcSEcCtD
Eprosartan—Dyspepsia—Doxorubicin—stomach cancer	0.000154	0.00058	CcSEcCtD
Eprosartan—Decreased appetite—Doxorubicin—stomach cancer	0.000152	0.000572	CcSEcCtD
Eprosartan—Fatigue—Doxorubicin—stomach cancer	0.000151	0.000568	CcSEcCtD
Eprosartan—Urticaria—Epirubicin—stomach cancer	0.00015	0.000565	CcSEcCtD
Eprosartan—Pain—Doxorubicin—stomach cancer	0.00015	0.000563	CcSEcCtD
Eprosartan—Constipation—Doxorubicin—stomach cancer	0.00015	0.000563	CcSEcCtD
Eprosartan—Body temperature increased—Epirubicin—stomach cancer	0.00015	0.000562	CcSEcCtD
Eprosartan—Abdominal pain—Epirubicin—stomach cancer	0.00015	0.000562	CcSEcCtD
Eprosartan—Hypersensitivity—Methotrexate—stomach cancer	0.000149	0.00056	CcSEcCtD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—stomach cancer	0.000145	0.00246	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—KISS1—stomach cancer	0.000145	0.00245	CbGpPWpGaD
Eprosartan—Asthenia—Methotrexate—stomach cancer	0.000145	0.000545	CcSEcCtD
Eprosartan—Feeling abnormal—Doxorubicin—stomach cancer	0.000144	0.000543	CcSEcCtD
Eprosartan—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000143	0.000538	CcSEcCtD
Eprosartan—Pruritus—Methotrexate—stomach cancer	0.000143	0.000538	CcSEcCtD
Eprosartan—Hypersensitivity—Epirubicin—stomach cancer	0.00014	0.000524	CcSEcCtD
Eprosartan—Urticaria—Doxorubicin—stomach cancer	0.000139	0.000523	CcSEcCtD
Eprosartan—Abdominal pain—Doxorubicin—stomach cancer	0.000139	0.00052	CcSEcCtD
Eprosartan—Body temperature increased—Doxorubicin—stomach cancer	0.000139	0.00052	CcSEcCtD
Eprosartan—Diarrhoea—Methotrexate—stomach cancer	0.000138	0.00052	CcSEcCtD
Eprosartan—AGTR1—GPCR downstream signaling—RGS2—stomach cancer	0.000138	0.00232	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—GAST—stomach cancer	0.000138	0.00232	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000137	0.00231	CbGpPWpGaD
Eprosartan—Asthenia—Epirubicin—stomach cancer	0.000136	0.00051	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—ADRB2—stomach cancer	0.000135	0.00227	CbGpPWpGaD
Eprosartan—Pruritus—Epirubicin—stomach cancer	0.000134	0.000503	CcSEcCtD
Eprosartan—Dizziness—Methotrexate—stomach cancer	0.000134	0.000503	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—GLI3—stomach cancer	0.000133	0.00225	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KISS1R—stomach cancer	0.000133	0.00225	CbGpPWpGaD
Eprosartan—Diarrhoea—Epirubicin—stomach cancer	0.00013	0.000487	CcSEcCtD
Eprosartan—Hypersensitivity—Doxorubicin—stomach cancer	0.000129	0.000485	CcSEcCtD
Eprosartan—Vomiting—Methotrexate—stomach cancer	0.000129	0.000483	CcSEcCtD
Eprosartan—Rash—Methotrexate—stomach cancer	0.000128	0.000479	CcSEcCtD
Eprosartan—Dermatitis—Methotrexate—stomach cancer	0.000127	0.000479	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—stomach cancer	0.000127	0.00215	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RBP1—stomach cancer	0.000127	0.00215	CbGpPWpGaD
Eprosartan—Headache—Methotrexate—stomach cancer	0.000127	0.000476	CcSEcCtD
Eprosartan—Asthenia—Doxorubicin—stomach cancer	0.000126	0.000472	CcSEcCtD
Eprosartan—Dizziness—Epirubicin—stomach cancer	0.000125	0.00047	CcSEcCtD
Eprosartan—AGTR1—Signaling by GPCR—GAST—stomach cancer	0.000125	0.00211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RGS2—stomach cancer	0.000125	0.00211	CbGpPWpGaD
Eprosartan—Pruritus—Doxorubicin—stomach cancer	0.000124	0.000466	CcSEcCtD
Eprosartan—Vomiting—Epirubicin—stomach cancer	0.00012	0.000452	CcSEcCtD
Eprosartan—Nausea—Methotrexate—stomach cancer	0.00012	0.000452	CcSEcCtD
Eprosartan—Diarrhoea—Doxorubicin—stomach cancer	0.00012	0.00045	CcSEcCtD
Eprosartan—Rash—Epirubicin—stomach cancer	0.000119	0.000449	CcSEcCtD
Eprosartan—Dermatitis—Epirubicin—stomach cancer	0.000119	0.000448	CcSEcCtD
Eprosartan—Headache—Epirubicin—stomach cancer	0.000119	0.000446	CcSEcCtD
Eprosartan—Dizziness—Doxorubicin—stomach cancer	0.000116	0.000435	CcSEcCtD
Eprosartan—Nausea—Epirubicin—stomach cancer	0.000112	0.000423	CcSEcCtD
Eprosartan—Vomiting—Doxorubicin—stomach cancer	0.000111	0.000419	CcSEcCtD
Eprosartan—Rash—Doxorubicin—stomach cancer	0.00011	0.000415	CcSEcCtD
Eprosartan—Dermatitis—Doxorubicin—stomach cancer	0.00011	0.000415	CcSEcCtD
Eprosartan—Headache—Doxorubicin—stomach cancer	0.00011	0.000412	CcSEcCtD
Eprosartan—CYP2C9—Biological oxidations—GSTT1—stomach cancer	0.000108	0.00183	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—CYP2A6—stomach cancer	0.000107	0.00181	CbGpPWpGaD
Eprosartan—CYP2C9—Arachidonic acid metabolism—PTGS2—stomach cancer	0.000105	0.00177	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AGTR2—stomach cancer	0.000104	0.00176	CbGpPWpGaD
Eprosartan—Nausea—Doxorubicin—stomach cancer	0.000104	0.000391	CcSEcCtD
Eprosartan—AGTR1—Signaling Pathways—WWOX—stomach cancer	0.000104	0.00175	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—F2R—stomach cancer	0.000103	0.00174	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—AKR1C3—stomach cancer	0.000103	0.00174	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—HTR1A—stomach cancer	0.0001	0.0017	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ANXA1—stomach cancer	9.69e-05	0.00164	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—WIF1—stomach cancer	9.63e-05	0.00163	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HRH4—stomach cancer	9.63e-05	0.00163	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AGTR2—stomach cancer	9.47e-05	0.0016	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADRB1—stomach cancer	9.39e-05	0.00159	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—F2R—stomach cancer	9.36e-05	0.00158	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	9.35e-05	0.00158	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR1A—stomach cancer	9.11e-05	0.00154	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKAB1—stomach cancer	8.88e-05	0.0015	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	8.86e-05	0.0015	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ANXA1—stomach cancer	8.8e-05	0.00149	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RNF43—stomach cancer	8.58e-05	0.00145	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KISS1—stomach cancer	8.58e-05	0.00145	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	8.53e-05	0.00144	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADRB1—stomach cancer	8.52e-05	0.00144	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	8.43e-05	0.00142	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	8.42e-05	0.00142	CbGpPWpGaD
Eprosartan—AGTR1—G alpha (q) signalling events—PIK3CA—stomach cancer	8.17e-05	0.00138	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	7.96e-05	0.00134	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	7.84e-05	0.00132	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FST—stomach cancer	7.65e-05	0.00129	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—ADRB2—stomach cancer	7.6e-05	0.00129	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GSTP1—stomach cancer	7.52e-05	0.00127	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HBEGF—stomach cancer	7.48e-05	0.00126	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTP1—stomach cancer	7.42e-05	0.00125	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RGS2—stomach cancer	7.38e-05	0.00125	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GAST—stomach cancer	7.38e-05	0.00125	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	7.31e-05	0.00124	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGG—stomach cancer	6.99e-05	0.00118	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—GSTM1—stomach cancer	6.91e-05	0.00117	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ADRB2—stomach cancer	6.91e-05	0.00117	CbGpPWpGaD
Eprosartan—CYP2C9—Metapathway biotransformation—GSTM1—stomach cancer	6.81e-05	0.00115	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PPP2R1A—stomach cancer	6.77e-05	0.00114	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	6.76e-05	0.00114	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKAA1—stomach cancer	6.73e-05	0.00114	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RBP4—stomach cancer	6.5e-05	0.0011	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL8—stomach cancer	6.5e-05	0.0011	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	6.47e-05	0.00109	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ACAD8—stomach cancer	6.46e-05	0.00109	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	6.32e-05	0.00107	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—HMOX1—stomach cancer	6.16e-05	0.00104	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	5.94e-05	0.001	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GMPR2—stomach cancer	5.76e-05	0.000974	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HSPB1—stomach cancer	5.59e-05	0.000945	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AGTR2—stomach cancer	5.59e-05	0.000945	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	5.56e-05	0.00094	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—F2R—stomach cancer	5.53e-05	0.000934	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BMP2—stomach cancer	5.53e-05	0.000934	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—RORA—stomach cancer	5.5e-05	0.000929	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKR1C3—stomach cancer	5.44e-05	0.000919	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR1A—stomach cancer	5.38e-05	0.00091	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—IDH3B—stomach cancer	5.27e-05	0.00089	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SUCLG1—stomach cancer	5.27e-05	0.00089	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PRKCB—stomach cancer	5.21e-05	0.000881	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ANXA1—stomach cancer	5.2e-05	0.000879	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRB1—stomach cancer	5.03e-05	0.000851	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NDUFV1—stomach cancer	4.9e-05	0.000828	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NDUFS1—stomach cancer	4.9e-05	0.000828	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RPS6—stomach cancer	4.81e-05	0.000813	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	4.79e-05	0.000809	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PRKCB—stomach cancer	4.73e-05	0.0008	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6ST—stomach cancer	4.71e-05	0.000797	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—APOA1—stomach cancer	4.67e-05	0.000789	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HBEGF—stomach cancer	4.42e-05	0.000747	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—BLVRB—stomach cancer	4.37e-05	0.000738	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PGLS—stomach cancer	4.37e-05	0.000738	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6R—stomach cancer	4.21e-05	0.000711	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—RHOA—stomach cancer	4.18e-05	0.000707	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPAP2A—stomach cancer	4.17e-05	0.000704	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRB2—stomach cancer	4.08e-05	0.000689	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	4.01e-05	0.000677	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PPP2R1A—stomach cancer	4e-05	0.000676	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—RHOA—stomach cancer	3.8e-05	0.000642	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CA1—stomach cancer	3.71e-05	0.000627	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FBP1—stomach cancer	3.71e-05	0.000627	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NDUFA2—stomach cancer	3.71e-05	0.000627	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CKB—stomach cancer	3.71e-05	0.000627	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SMAD4—stomach cancer	3.71e-05	0.000627	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—stomach cancer	3.7e-05	0.000625	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL8—stomach cancer	3.67e-05	0.000621	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FYN—stomach cancer	3.52e-05	0.000596	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLIN2—stomach cancer	3.49e-05	0.00059	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CA2—stomach cancer	3.4e-05	0.000574	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL8—stomach cancer	3.34e-05	0.000564	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NT5E—stomach cancer	3.31e-05	0.000559	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PGAM1—stomach cancer	3.31e-05	0.000559	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGFR2—stomach cancer	3.31e-05	0.000559	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLCE1—stomach cancer	3.16e-05	0.000533	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDH7A1—stomach cancer	3.16e-05	0.000533	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IRS2—stomach cancer	3.03e-05	0.000512	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UMPS—stomach cancer	3.03e-05	0.000511	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CAV1—stomach cancer	2.94e-05	0.000496	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOA1—stomach cancer	2.93e-05	0.000495	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PDHA1—stomach cancer	2.81e-05	0.000475	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ECHS1—stomach cancer	2.81e-05	0.000475	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCB—stomach cancer	2.8e-05	0.000472	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6ST—stomach cancer	2.78e-05	0.000471	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APC—stomach cancer	2.68e-05	0.000452	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TYMP—stomach cancer	2.65e-05	0.000447	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—FADS1—stomach cancer	2.65e-05	0.000447	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MAPK3—stomach cancer	2.56e-05	0.000433	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6R—stomach cancer	2.48e-05	0.00042	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SREBF2—stomach cancer	2.48e-05	0.000419	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—RORA—stomach cancer	2.45e-05	0.000414	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MAPK1—stomach cancer	2.44e-05	0.000412	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—EGFR—stomach cancer	2.44e-05	0.000412	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CA—stomach cancer	2.33e-05	0.000394	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SERPINE1—stomach cancer	2.33e-05	0.000393	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—KRAS—stomach cancer	2.3e-05	0.000389	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDOB—stomach cancer	2.29e-05	0.000388	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RHOA—stomach cancer	2.24e-05	0.000379	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOS3—stomach cancer	2.22e-05	0.000375	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.16e-05	0.000365	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.16e-05	0.000365	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALOX5—stomach cancer	2.13e-05	0.00036	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CA—stomach cancer	2.12e-05	0.000358	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DPYD—stomach cancer	2.1e-05	0.000354	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ERBB2—stomach cancer	2.08e-05	0.000351	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL8—stomach cancer	1.97e-05	0.000333	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HRAS—stomach cancer	1.96e-05	0.000331	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDKN1B—stomach cancer	1.92e-05	0.000325	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.9e-05	0.000321	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—stomach cancer	1.87e-05	0.000317	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTT1—stomach cancer	1.85e-05	0.000313	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCND1—stomach cancer	1.84e-05	0.00031	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2A6—stomach cancer	1.83e-05	0.00031	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—JUN—stomach cancer	1.83e-05	0.00031	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.78e-05	0.000301	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—stomach cancer	1.78e-05	0.000301	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CDKN1A—stomach cancer	1.78e-05	0.0003	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ENO1—stomach cancer	1.74e-05	0.000294	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK8—stomach cancer	1.73e-05	0.000293	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.71e-05	0.000289	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—stomach cancer	1.6e-05	0.00027	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—STAT3—stomach cancer	1.58e-05	0.000268	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CD44—stomach cancer	1.54e-05	0.000261	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK3—stomach cancer	1.51e-05	0.000256	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.5e-05	0.000253	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MYC—stomach cancer	1.47e-05	0.000249	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK1—stomach cancer	1.44e-05	0.000243	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EGFR—stomach cancer	1.44e-05	0.000243	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KRAS—stomach cancer	1.36e-05	0.00023	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPP2R1A—stomach cancer	1.31e-05	0.000222	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTP1—stomach cancer	1.29e-05	0.000217	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMOX1—stomach cancer	1.27e-05	0.000214	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CA—stomach cancer	1.25e-05	0.000211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TP53—stomach cancer	1.21e-05	0.000204	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TYMS—stomach cancer	1.2e-05	0.000202	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTM1—stomach cancer	1.18e-05	0.0002	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HRAS—stomach cancer	1.16e-05	0.000195	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ERCC2—stomach cancer	1.11e-05	0.000188	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—stomach cancer	1.11e-05	0.000187	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—stomach cancer	1.04e-05	0.000176	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAV1—stomach cancer	9.63e-06	0.000163	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOA1—stomach cancer	9.61e-06	0.000162	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.2e-06	0.000156	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARG—stomach cancer	8.47e-06	0.000143	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—stomach cancer	7.61e-06	0.000129	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NOS3—stomach cancer	7.28e-06	0.000123	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—stomach cancer	6.66e-06	0.000113	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CA—stomach cancer	4.1e-06	6.93e-05	CbGpPWpGaD
